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Cardiac catheterization is one of the common-
est procedures done worldwide. Although the risks
of the procedure are small, it is plagued by patient
dissatisfaction due to the prolonged bed rest after
the procedure and groin bleeding related to the fem-
oral artery puncture site. There have been many
attempts to decrease or eliminate the bed rest post-
procedure, including the development of numerous
percutaneous vascular closure devices, using small-
er catheters and hemostatic patches. Although
these devices in general achieve faster ambulation
time, none have been shown to decrease bleeding
complications and they all add cost to the procedure
[1–4].
Radial artery catheterization offers the unique
combination of less bleeding, better patient satis-
faction and early ambulation without an increased
cost to the system [5–7]. Despite these advantag-
es, radial access has been very slowly adopted. In-
terventionalists have quickly adopted many new
techniques that were shown to benefit patients, so
why not the radial approach to cardiac catheteriza-
tion?
The best answer may be the convincing data/
work to change (CD/WC) ratio. I would propose this
as a novel barometer of predicting when there will
be a shift in medical practice. Physicians will rarely
change their way of doing things until the CD/WC
ratio is significantly greater than 1. If we look at re-
cent new techniques in interventional cardiology,
we can see how the CD/WC ratio affects practices.
One the quickest changes that occurred in interven-
tional cardiology was the adoption of drug eluting
stents (DES). The randomized data for the preven-
tion of re-stenosis was overwhelming [8] and the
techniques needed to adapt to this change were no
different than using bare metal stents. This gave
DES a CD/WC ratio much greater than one. On the
opposite side is the use of rotational and direction-
al atherectomy. Here there is limited data in rand-
omized trials of any patient benefit [9] and these
procedures require a significant amount of training
and new techniques to be successful. So the CD/
/WC ratio is less than one with atherectomy; there-
fore a cardiologist’s use of these devices is limited.
So what is the CD/WC ratio of radial artery
catheterization? At this point it is approaching 1 but
not close enough for interventionalists worldwide
to change their approach in large numbers. Decreas-
ing the work to change (WC) is the first barrier that
has to be overcome. Because of the radial artery’s
small size, vascular anomalies and its tendency to
spasm reaching the central aorta can be difficult. But
with appropriate training and experience, success
rates with the radial technique can approach the
rates with femoral cases, even in complex patients
[10, 11]. In addition to better training, better equip-
ment is also making the technique less difficult.
With new sheaths for radial access, better cathe-
ters for guide support and lower profile balloons and
stents, never before has radial access been easier.
The more operators adopt the radial technique, the
more the medical device industry will improve the
tools we use.
Despite these advances it is unlikely that there
will be a large decrease in the WC, so if the CD/
/WC ratio is going to be greater than 1, there needs
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to be a large increase in the amount of convincing
data (CD). The article by Chodór et al. [12] in this
month’s edition of “Cardiology Journal” helps in-
crease the CD for radial artery catheterizations. The
amount of data needed to change physicians’ prac-
tices is difficult to assess. The quality of the data
may be more important that the quantity. Data that
comes from high quality studies is more likely to
be accepted as true by the cardiology community.
There is growing evidence that bleeding in
patients with acute coronary syndromes is associ-
ated with increased mortality [13–17]. The etiolo-
gy is unclear but may be related to anemia causing
increased ischemic events, impaired renal function
and platelet activation. In addition, blood transfu-
sions can lead to activation of the inflammatory
process and progression of atherosclerosis [18]. So,
given this information, it is not surprising that
a meta-analysis of nearly 39,000 procedures done
in British Columbia found that the use of radial ar-
tery catheterizations halved the transfusion rate and
was associated with a significant reduction in the
30 day and 1 year mortality rate; odds ratio = 0.71
and 0.83 respectively with a p value < 0.001 [19].
This data is consistent with the RIVIERA
study, a large prospective, international registry
which reported a decrease in bleeding complications
and a reduction in percutaneous coronary interven-
tion related mortality [20]. Similarly in the ‘real
world’ study PREVAIL, which was a prospective
look at 1,000 consecutive patients undergoing per-
cutaneous procedures via arterial access, radial
artery access was associated with less bleeding and
lower in-hospital mortality [21]. The difficulty with
all of these studies is that they are observational
and it is difficult to control all the possible confound-
ers. Since they are not randomized, there is a pos-
sible selection bias that cannot be controlled. The
impact on the CD will be blunted because of this.
Until there is a large randomized trial of radial ver-
sus femoral arterial access, it is unlikely that the
CD/WC ratio will be significantly greater than 1.
There was one prospective, randomized clinical trial
that did show benefit to radial access with less
bleeding, but because of the higher access site fail-
ures and because it was more than 10 years ago, its
effect was minimal [6].
The article by Chodór et al. [12] in this issue
of “Cardiology Journal” is unique in two regards. It
is one of the few prospective, randomized trials of
radial access and it also shows that the use of ra-
dials in acute myocardial infarction is possible.
Because of this, it significantly adds to the CD and
pushes the CD/WC ratio closer to 1. There is limited
data for the use of radials in acute myocardial inf-
arction, as Chodór points out. Although this present
trial is small, it clearly shows that radial artery im-
proved the time to ambulation with no increase in
the overall time of procedure, fluoroscopy time or
volume of contrast. The study was not powered to
look for complications but it is encouraging that
there was a trend toward a decreased transfusion
rate (p = 0.08). The major criticism of this study is
the increase in door to balloon time in the radial
access arm. Chodór’s data shows this is due to
sheath positioning and guide catheter placement.
Any increase in door to balloon time in primary an-
gioplasty has the potential to increase the mortali-
ty rate of acute myocardial infarction patients. If
radial artery is to be used commonly in primary
angioplasty there should be no difference in door
to balloon time between radial and femoral arterial
access. This can be done with more experience and
better tools (decreasing the WC). At the Universi-
ty of Rochester Medical Center, the door to balloon
times are similar between radial and femoral oper-
ators [22]. This has only been achieved through
experience and training.
It is encouraging to see more data pushing the
CD/WC ratio in favor of radial artery. As the evi-
dence mounts and experience grows, we will be able
to offer patients a better procedure that offers more
comfort, decreased complications, and at a lower
cost.
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